Colombia | BCH-DEC-CO-105612 | Country's Decision or any other Communication | Biosafety Clearing-House
CBD / BCH / Search / Record

Loading...
Country's Decision or any other Communication (DEC)
  |  
BCH-DEC-CO-105612-1   |   PDF   |   Print   |  
| 
|  Close
last updated: 12 Jun 2014
Amendment
No
General Information
Colombia
Resolución 1252: Por la cual se autoriza el uso ( importación y comercialización) a los Laboratorios Wyeth Inc del producto Poulvac® E. Coli con destino al control de la Colibacilosis en aves de corral, cuyo titular es la empresa FORD DODGE ANIMAL HELTH
ES
09 Apr 2010
No
Subject of the decision, notification, communication or declaration
  • Decision on Pharmaceuticals (Article 5)
LMO identification & risk assessment
  • BCH-LMO-SCBD-105185-1 Living Modified Organism Poulvac® ST vaccine
    Fort Dodge Saúde Animal | Production of medical or pharmaceutical compounds (human or animal) (Vaccines)
  • BCH-RA-CO-105611-1 Risk Assessment generated by a regulatory process Uso del producto Poulvac® E. Coli con destino al control de la Colibacilosis en aves de corral, cuyo titular es la empresa FORD DODGE ANIMAL HELTH
    Poulvac® ST vaccine | SALTM, Production of medical or pharmaceutical compounds (human or animal)
Document on the decision, communication, notification or declaration

Quick links

About the BCH About the Cartagena Protocol Supplementary Protocol

Sign in Search records Submit records
Registries: LMO-Organism-Gene Country Profiles
National Report Analyzer

Forums BCH Announcements

Need help?

Knowledge Base FAQs Training Materials Training Site

Contact us at: bch@cbd.int
BCH Biosafety Clearing-House
Subscribe to e-mail notifications
Subscribe to our newsletter